Liposome-encapsulated mitoxantrone hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Liposome-encapsulated mitoxantrone hydrochloride, covering 2023-03-17 to 2023-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma [Phase 2]